Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits
- PMID: 36251504
- PMCID: PMC10078276
- DOI: 10.1002/hup.2856
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits
Abstract
Objectives: This research aimed to systematically review the acute effects of amphetamine (AMP), a dopamine-releasing agent, on working memory (WM) and other cognitive performances. The investigation also aimed to review the impact of personality traits on the subjective and objective effects of AMP and possible links between personality traits and effects of AMP.
Methods: Previous double-blind controlled studies assessing the main effects of AMP on WM and other cognitive performances in healthy volunteers were systematically reviewed. An electronic search was performed in the PUBMED and SCOPUS databases. Narrative reviews of the influence of personality traits on the subjective and objective effects of AMP were included.
Results: Nineteen WM studies were included in the current review. Seven studies found effects of AMP on spatial WM, but only one study found the effect of AMP on verbal WM. Thirty-seven independent studies on other aspects of cognitive performance were identified. Twenty-two reported effects of AMP on cognitive functions. Studies also showed that personality traits are associated with the subjective effects of AMP. However, few studies reported the impacts of personality traits on the objective (such as WM) effects of AMP.
Conclusion: Overall, findings indicate that AMP has mixed-effects on spatial WM and other cognitive functions, but it lacks effects on verbal WM. Although there are insufficient studies on objective measures, studies also indicated that the subjective effects of AMP administration are linked to between-person variations in personality traits.
Keywords: amphetamine; cognitive impairment; dopamine; personality trait; working memory.
© 2022 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd.
Conflict of interest statement
The author declare that there is no conflict of interest.
Figures
Similar articles
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Selegiline for Alzheimer's disease.Cochrane Database Syst Rev. 2003;(1):CD000442. doi: 10.1002/14651858.CD000442. Cochrane Database Syst Rev. 2003. PMID: 12535396
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. PMID: 14584018 Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Cited by
-
The effects of caffeine and d-amphetamine on spatial span task in healthy participants.PLoS One. 2023 Jul 13;18(7):e0287538. doi: 10.1371/journal.pone.0287538. eCollection 2023. PLoS One. 2023. PMID: 37440493 Free PMC article. Clinical Trial.
References
-
- Abi‐Dargham, A. , Kegeles, L. S. , Zea‐Ponce, Y. , Mawlawi, O. , Martinez, D. , Mitropoulou, V. , O'Flynn, K. , Koenigsberg, H. W. , Van Heertum, R. , Cooper, T. , Laruelle, M. , & Siever, L. J. (2004). Striatal amphetamine‐induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biological Psychiatry, 55(10), 1001–1006. 10.1016/j.biopsych.2004.01.018 - DOI - PubMed
-
- Abi‐Dargham, A. , Mawlawi, O. , Lombardo, I. , Gil, R. , Martinez, D. , Huang, Y. , Hwang, D. R. , Keilp, J. , Kochan, L. , Van Heertum, R. , Gorman, J. M. , & Laruelle, M. (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. Journal of Neuroscience, 22(9), 3708–3719. 10.1523/jneurosci.22-09-03708.2002 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources